Clover Biopharmaceuticals Raises $230 Million to Expand Trimer-Tag Technology
On February 23rd, Chengdu-based Clover Biopharmaceuticals announced the completion of an oversubscribed Series C funding round of $230 million. The funds will be directed mainly for the pipeline expansion on …
Read More